Position in RLAY
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$13,751
+$6,438 QoQ
Shares Held
735
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#231
of 256 holders
Holding Since
Sep 2025
4 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in RLAY Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026UMB Bank, n.a. holds $4,194,544 across 50 Biotechnology names. RLAY ranks #35 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,459 | $724,728 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,060 | $660,951 | |
| 3 | JAZZ |
Jazz Pharmaceuticals plc
|
1,123 | $270,609 | |
| 4 | ROIV |
Roivant Sciences Ltd.
|
6,720 | $237,820 | |
| 5 | TECH |
BIO-TECHNE Corp
|
3,337 | $235,759 | |
| 6 | VIR |
Vir Biotechnology, Inc.
|
19,624 | $199,968 | |
| 7 | EXEL |
Exelixis, Inc.
|
3,413 | $185,701 | |
| 8 | CYTK |
Cytokinetics Inc
|
1,930 | $164,415 |
All Filings in RLAY
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $13,751 | 735 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $7,313 | 735 | Shares | Defined | 2026-05-11 | |
| 2025-12-31 | $6,218 | 735 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $3,836 | 735 | Shares | Defined | 2025-11-04 | |
| No filing history on record for this holder in this stock. | ||||||